Publication

Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma

ANNÉE

2021

AUTEURS

Giraud P, Racadot S, Vernerey D, Goldstein D, Glimelius B, Van Houtte P, Gubanski M, Spry N, Van Laethem JL, Hammel P, Huguet F

CONGRÈS/REVUE

Int J Radiat Oncol Biol Phys

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ijrobp.2021.01.055

Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma

ANNÉE

2021

AUTEURS

Schernberg A, Vernerey D, Goldstein D, Van Laethem JL, Glimelius B, van Houtte P, Bonnetain F, Louvet C, Hammel P, Huguet F

CONGRÈS/REVUE

Int J Radiat Oncol Biol Phys

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ijrobp.2021.01.052

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

ANNÉE

2021

AUTEURS

Quénet F, Elias D, Roca L, Goéré D, Ghouti L, Pocard M, Facy O, Arvieux C, Lorimier G, Pezet D, Marchal F, Loi V, Meeus P, Juzyna B, de Forges H, Paineau J, Glehen O, UNICANCER-GI Group and BIG Renape Group

CONGRÈS/REVUE

Lancet Oncol

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/s1470-2045(20)30599-4

FOLFIRINEC: A Randomized Phase II Trial of MFOLFIRINOX vs Platinum-Etoposide for Metastatic Neuroendocrine Carcinoma of Gastroenteropancreatic or Unknown Origin

ANNÉE

2021

AUTEURS

Hadoux J, Afchain P, Walter T, Tougeron D, Hautefeuille V, Monterymard C, Lorgis V, Thuillier F, Baudin E, Scoazec J. Y, Lepage C, Desgrippes R

CONGRÈS/REVUE

Dig Liver Dis

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.dld.2021.04.016

PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)

ANNÉE

2021

AUTEURS

Ducreux Ml, Parzy A, Ben Abdelghani M, Martin-Babau J, Tougeron D, Botsen D, Taieb J, Pannier D, Khemissa F, Viaud J, Villing AL, Bouché O, Peytier A, Alexandre H, Garic F, Tanguy M-L, Bachet J-B

CONGRÈS/REVUE

ESMO

LIEN PUBLICATIONS ASSOCIÉES

https://cslide.ctimeetingtech.com/esmo2021/public/download_uploaded_media/pdf/722

A randomized non-comparative phase II study of maintenance therapy with FOLFIRI alone or in combination with Tedopi vaccine after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (TEDOPAM D17-01 PRODIGE 63 STUDY)

ANNÉE

2021

AUTEURS

Hilmi M, Hautefeuille V, Lambert A, Garcia-Larnicol ML, Vernerey D, Neuzillet C,

CONGRÈS/REVUE

ESMO

LIEN PUBLICATIONS ASSOCIÉES

https://oncologypro.esmo.org/meeting-resources/esmo-congress-2021/a-randomized-non-comparative-phase-ii-study-of-maintenance-therapy-with-folfiri-alone-or-in-combination-with-tedopi-vaccine-after-induction-therapy

A randomized non-comparative phase II study of maintenance therapy with FOLFIRI alone or in combination with Tedopi vaccine after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (TEDOPAM D17-01 PRODIGE 63 STUDY)

ANNÉE

2021

AUTEURS

HiImi M, Hautefeuille V, Lambert A, Garcia-Larnicol ML, Vernerey D, Neuzillet C

CONGRÈS/REVUE

ESMO

LIEN PUBLICATIONS ASSOCIÉES

https://cslide.ctimeetingtech.com/esmo2021/public/download_uploaded_media/pdf/1921

Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial

ANNÉE

2021

AUTEURS

Boileve A, Hilmi M, Gougis P, Cohen R, Rousseau B, Blanc JF, Ben Abdelghani M, Castanie H, Dahan L, Tougeron D, Metges JP, Tournigand C, Garcia-Larnicol ML, Vernerey D, Turpin A, Neuzillet C

CONGRÈS/REVUE

Eur J Cancer

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1016/j.ejca.2020.10.027

NACRE: A randomized study comparing short course radiotherapy with radiochemotherapy for locally advanced rectal cancers in the elderlyPreliminary results

ANNÉE

2021

AUTEURS

Francois E, Pernot M, Ronchin P, Nouhaud E, Lafay I, Pascal A , Clavere P, Vendrely V, Boige V , Thamphya B, Ficher S, Magné N

CONGRÈS/REVUE

ASCO GI

LIEN PUBLICATIONS ASSOCIÉES

https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.3_suppl.4

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

ANNÉE

2021

AUTEURS

Dahan L, Williet N, Le Malicot K, Phelip JM, Desrame J, Bouche O, Petorin C, Malka D, Rebischung C, Aparicio T, Lecaille C, Rinaldi Y, Turpin A, Bignon AL, Bachet JB, Seitz JF, Lepage C, Francois E, PRODIGE 35 Investigators/Collaborators

CONGRÈS/REVUE

J Clin Oncol

LIEN PUBLICATIONS ASSOCIÉES

https://doi.org/10.1200/jco.20.03329